FINWIRES · TerminalLIVE
FINWIRES

$MEDP

9 stories mentioning MEDPUpdated 7d ago

Every FINWIRES story that references MEDP, newest first.

Insider Trading

Medpace Holdings Insider Sold Shares Worth $4,500,000, According to a Recent SEC Filing

Susan E Burwig, Executive Vice President, Operations, on July 28, 2026, sold 7,500 shares in Medpace Holdings (MEDP) for $4,500,000. Following the Form 4 filing with the SEC, Burwig has control over a total of 62,984 common shares of the company, with 62,984 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1668397/000167741826000008/xslF345X05/wk-form4_1785357140.xml

$MEDP
Wire

Medpace's Bookings Recovery, Normalization of Cancellations Support Growth, RBC Says

Medpace's (MEDP) recovery in bookings, normalization of cancellations, and pre-backlog pipeline support its growth into 2027, RBC Capital Markets said in a note Thursday.The company's Request for Proposal, or RFP, grew "meaningfully" in Q2 from a year earlier, and pre-backlog awards continued growing faster than backlog itself, the investment firm said.Management expects net bookings to ramp "quite a bit" in H2, provided there isn't a rise in cancellations, according to the note.The firm said Medpace's interim burn rate is expected to remain elevated before a potential gradual decline over the next couple of years as new bookings scale.RBC Capital Markets retained an outperform rating on the stock and increased its price target to $692 from $484.Price: $605.76, Change: $-0.06, Percent Change: -0.01%

$MEDP
Research

RBC Raises Price Target on Medpace Holdings to $692 From $484, Keeps Outperform Rating

Medpace Holdings (MEDP) has an average rating of hold and mean price target of $588.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$MEDP
Wire

Update: Medpace Shares Rise After Q2 Beat

(Updates with the company's latest stock move in the headline and the first paragraph.)Medpace (MEDP) shares surged more than 15.5% in Thursday trading after the company reported stronger-than-expected Q2 earnings and revenue late Wednesday.The company posted Q2 earnings of $4.25 per diluted share, up from $3.10 a year earlier.Analysts polled by FactSet expected $3.98.Revenue for the quarter ended June 30 was $707.3 million, up from $603.3 million a year ago.Analysts expected $689.5 million.For full-year 2026, the company expects EPS of $17.25 to $17.95 per share on revenue of $2.81 billion to $2.89 billion.Analysts expect $16.97 on revenue of $2.77 billion.Price: $610.09, Change: $+81.97, Percent Change: +15.52%

$MEDP
Wire

Medpace Shares Fall After Baird Downgrade

Medpace (MEDP) shares fell 3.2% on Wednesday after Baird downgraded the stock to neutral from outperform and adjusted its price target to $547 per share from $477.Trading volume stood at around 230,600 shares compared with a daily average of 375,188.Price: $528.74, Change: $-17.55, Percent Change: -3.21%

$MEDP
Research

Baird Downgrades Medpace to Neutral From Outperform, Adjusts PT to $547 From $477

Medpace Holdings (MEDP) has an average rating of Hold and mean price target of $462.55, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$MEDP
Wire

Truist Adjusts Price Target on Medpace to $462 From $539, Maintains Hold Rating

Medpace (MEDP) has an average rating of hold and mean price target of $457.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $391.52, Change: $-1.90, Percent Change: -0.48%

$MEDP
Wire

Deutsche Bank Cuts Price Target on Medpace Holdings to $425 From $480, Keeps Hold Rating

Medpace Holdings (MEDP) has an average rating of hold and mean price target of $510.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $382.61, Change: $-125.85, Percent Change: -24.75%

$MEDP
Wire

Medpace Q1 Earnings, Revenue Rise

Medpace (MEDP) reported Q1 earnings late Wednesday of $4.28 per diluted share, up from $3.67 a year earlier.Analysts surveyed by FactSet expected $3.92.Revenue for the three months ended March 31 was $706.6 million, up from $558.6 million a year earlier.Analysts polled by FactSet expected $697.6 million.For 2026, the company expects EPS of $16.68 to $17.50 on revenue of $2.76 billion to $2.86 billion. Analysts expect EPS of $17.16 on revenue of $2.81 billion.The company said Jesse Geiger notified his intention to resign as president and that he will retire effective May 31. CEO August Troendle will reassume the role of president until a successor is appointed, the company added.

$MEDP

Track with the FINWIRES app suite

FolioX
FolioX
Track MEDP in your portfolio
WheelAI
WheelAI
Analyze MEDP options with the wheel strategy
StockInsider
StockInsider
See market sentiment on MEDP